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Abstract
Many heme enzymes show remarkable versatility and atypical kinetics. The fungal extracellular enzyme chloroperoxidase
(CPO) characterizes a variety of one and two electron redox reactions in the presence of hydroperoxides. A structural
counterpart, found in mammalian microsomal cytochrome P450 (CYP), uses molecular oxygen plus NADPH for the oxidative
metabolism (predominantly hydroxylation) of substrate in conjunction with a redox partner enzyme, cytochrome P450
reductase. In this study, we employ the two above-mentioned heme-thiolate proteins to probe the reaction kinetics and
mechanism of heme enzymes. Hitherto, a substrate inhibition model based upon non-productive binding of substrate (two-
site model) was used to account for the inhibition of reaction at higher substrate concentrations for the CYP reaction
systems. Herein, the observation of substrate inhibition is shown for both peroxide and final substrate in CPO catalyzed
peroxidations. Further, analogy is drawn in the ‘‘steady state kinetics’’ of CPO and CYP reaction systems. New experimental
observations and analyses indicate that a scheme of competing reactions (involving primary product with enzyme or other
reaction components/intermediates) is relevant in such complex reaction mixtures. The presence of non-selective reactive
intermediate(s) affords alternate reaction routes at various substrate/product concentrations, thereby leading to a lowered
detectable concentration of ‘‘the product of interest’’ in the reaction milieu. Occam’s razor favors the new hypothesis. With
the new hypothesis as foundation, a new biphasic treatment to analyze the kinetics is put forth. We also introduce a key
concept of ‘‘substrate concentration at maximum observed rate’’. The new treatment affords a more acceptable fit for
observable experimental kinetic data of heme redox enzymes.
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Introduction
Hemoproteins serve multiple roles in the cellular biochemistry
and as a result, they are one of the well-studied proteins. Structure-
function similarities as well as disparities can be drawn between
the two heme proteins, chloroperoxidase (CPO) and cytochrome
P450 (CYP). The former is a highly stable glycosylated
extracellular acidic protein with a constrained and polar active
site [1]. The latter is a relatively sensitive microsomal membranous
protein showing little post translational modifications, but with a
larger hydrophobic active site [2,3]. Though both are ,45 KD
mass and ,45 A ˚ in dimensions, they bear only ,25% sequence
similarities. The most important common structural element is the
proximal thiolate ligand, bound to the central iron of heme
(protoporphyrin IX). The formal charge on iron at the resting state
is 3
+and the spin state may change based on the distal ligand and
microenvironment. Both these enzymes are well-studied enzyme
systems, characteristically marked for their versatility in the
number of reactions they can catalyze [4–7]. Both CPO and
CYPs are known for a relative lack of specificity in substrate
preferences. Chloroperoxidase is a classical peroxygenase carrying
out its oxidations with hydroperoxide as the ancillary activator [8].
CYP is a typical monooxygenase which requires a ternary mixture
of molecular oxygen, yet another enzyme called cytochrome P450
reductase (CPR) and redox equivalents from NADPH [9].
Our recent explorations with chloroperoxidase catalyzed
peroxidations had afforded some interesting and unexpected
results. To account for these observations, we had reasoned out
that some of the enzyme-substrate (final acceptor) interactions
might not go through the typical enzyme-substrate binding [10] at
a unique active site of the enzyme. As a result, they may not be
defined by the classical Michaelis-Menten kinetics. While pursuing
the newly discovered angles on the single electron peroxidations of
CPO, we found some analogies with the two-electron CYP
catalyzed oxygen insertion reactions, pertaining to the ‘‘inhibition
of reaction’’ at higher substrate concentrations. Approximately
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inhibition. Hitherto, such atypical kinetic behavior was attributed
to a mechanistic scheme involving alternate substrate binding
site(s) near the CYP enzyme’s active site[11–14], which is a two-
site binding model, as shown in Figure 1.
We present evidence and argue herein that it is highly unlikely
that both CPO and the CYP family of enzymes (as exemplified by
CYPs 2C9, 2E1 & 1A2) possess multiple binding sites for their
diverse array of substrates. To explain for the ‘substrate
inhibition’, we propose an alternative hypothesis which involves
enzyme-free reactions of the substrates, product(s) and transient
intermediate(s). We also present an alternative model for fitting the
data obtained, to give meaningful indices of the reaction system.
Results
CPO mediated peroxidations of ABTS, TMPD and
Pyrogallol
To derive an overview of the steady-state reaction profiles, the
substrate molecules’ concentrations were varied over three
decades. Kinetic data obtained for the production of stable cation
radicals and condensed products were noted within the first few
tens of seconds of reaction are summarized in Table 1.
For all reactions studied, increasing the final peroxidative
substrates’ concentration (at an initial constant peroxide concen-
tration) generally gave an increase in the reaction rates for the sub-
millimolar reaction range studied (Figure 2 is a salient example for
ABTS, other data are shown in Table 1), which could be fit to
non-linear regression of Michaelis-Menten equation, with R
2
values above 0.9. However, the data could not be transformed to
fit the popular linearized models exemplified by Lineweaver-Burk
or Eadie-Hofstee (results not shown). Also, incrementing the first
substrate concentration by decades did not give corresponding
levels of increase in second substrate conversion, as expected in
Figure 1 (left side). The reaction profiles obtained by varying
peroxide concentrations at constant peroxidative substrate con-
centration gave mixed trends (Figure 3 & Table 1 show the profile
for TMPD). The increase in peroxide concentrations gave an
apparent inhibition at higher concentrations, the extent of which
varied with different peroxidative substrates. Again, none of these
profiles could be fit to a non-linear substrate inhibition model
within an extension of the Michaelis-Menten paradigm (as
exemplified by the Belanger fit [15]) to give global and
reproducible constants with accuracy and precision (Table 1).
Figure 4 shows that a substrate like pyrogallol, which showed
lower inhibitions with peroxide increments, also exhibited lowered
product (purpurogallin) formation at supra-millimolar concentra-
tions of pyrogallol. The inhibition was also seen for an active site
excluded substrate like ABTS (inset of Figure 4). When the two sets
of data (rates obtained by varying peroxide at constant final
peroxidative substrate versus rates obtained by varying final
peroxidative substrate at constant peroxide) were compared, it
could be seen that increase in peroxide (at constant peroxidative
substrate) had a greater effect on lowering rate. In most cases, the
Belanger fit curves did not justifiably cover the data points at
higher substrate concentrations (data not shown).
CYP2E1 reactions with pNP
Figures 5 & 6 and Table 2 depict the result when substrate effect
was probed in two reaction systems- (1) employing NADPH
regeneration system with enzymes to remove reduced oxygen
species (ROS) and (2) directly with NADPH and without enzymes
included to remove ROS. In both these reaction systems,
employment of moderate amounts of Cytb5 enhanced the product
formation at lower substrate concentrations when compared to the
controls. Notably, the first setup gave much higher yields of
product in comparison to the second. However, incorporation of
excess Cytb5 gave similar product formations (especially at higher
Figure 1. The usual or unusual kinetic profiles and their mechanistic explanations hitherto available are shown. The profile at top-left
shows kinetics via a simple Michaelis-Menten bisubstrate mechanism, corresponding to a mechanistic scheme shown at top-right. At bottom-left is
the substrate inhibited kinetics profile, which is explained mechanistically at the bottom-right.
doi:10.1371/journal.pone.0010601.g001
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concentration and reproducibility was probed and the results are
shown in Figure 7 & Table 2. Clearly, the magnitude of KIS varied
from one experiment to another significantly. The reaction profile
was charted in detail by taking a 16 point curve (Figure 8), which
showed that the descending part of the Belanger fit (after inflexion)
significantly deviated from the experimental points. A theoretical
simulation using the double hyperbolic combination showed a
similar profile as the experimentally determined points (Figure 8).
CYP2C9 reactions with diclofenac
Figure 9 shows the 49hydroxylated product obtained for
diclofenac’s reaction with two concentrations of CYP2C9. The
CYP concentration was shown to have pronounced effect on the
value of constants (quite like the results with CYP2E1) and the
‘‘substrate inhibition’’ was more pronounced at higher enzyme
concentration. When a similar reaction setup was probed with
respect to product formation at various time intervals (Figure 10),
it was noted that the formed product disappeared for higher
substrate concentration. Incorporation of Cytb5 lowered the
Table 1. Analyses of CPO catalyzed peroxidations by Belanger fits.
Substrate Reaction Setup KM (mM) Vmax (s
21)K IS (mM) R
2
Peroxide 25 mM ABTS 0.1160.04 0–0.24 17.563.4 6.8–28.3 0.6760.21 0–1.3 0.991
0.25 mM ABTS 0.1160.15 0–0.58 102671 0–326 0.3960.39 0–1.6 0.953
2.5 mM ABTS 0.1460.08 0–0.40 202645 60–344 2.361.1 0–5.8 0.930
25 mM TMPD 0.0160.03 0–0.08 44.566.8 29.2–59.8 86.66234 0–616 0.014
0.25 mM TMPD 0.1260.06 0–0.26 421680 240–601 1.960.75 0.2–3.6 0.835
2.5 mM TMPD 0.4660.2 0.01–0.92 20146378 1158–2869 5.562.2 0.5–10.6 0.879
25 mM Pyrogallol 0.0860.05 0–0.19 761 4.8–9.3 15.169.8 0–37.4 0.461
0.25 mM Pyrogallol 0.0860.02 0.04–0.13 59.262.9 52.7–65.8 13.662.9 7.1–20 0.879
2.5 mM Pyrogallol 1.0560.12 0.79–1.33 509628 446–572 29.167 13.3–45 0.995
ABTS 0.1 mM Peroxide 0.3760.03 0.30–0.45 44.661.3 41.6–47.5 Nd 0.994
1 mM Peroxide 0.9160.14 0.59–1.22 76.265.3 64.5–87.9 Nd 0.989
10 mM Peroxide 1.9660.21 1.48–2.43 2361.5 19.8–26.2 Nd 0.997
TMPD 0.1 mM Peroxide 0.5860.18 0.09–1.08 188622 126–250 Nd 0.973
1 mM Peroxide 3.261 0.41–6.03 1366628 566–2166 Nd 0.995
10 mM Peroxide 9.164.2 0.0–20.9 20996820 0–4377 Nd 0.998
Pyrogallol 0.1 mM Peroxide 0.1360.05 0.03–0.23 36.363.2 29.1–43.5 Nd 0.908
1 mM Peroxide 1.4360.31 0.75–2.12 312635 235–389 Nd 0.985
10 mM Peroxide 13.463.6 5.43–21.5 22106523 1045–3375 Nd 0.999
2 mM Peroxide* 9.0562.8 3.2–14.9 18466212 1400–2292 168639 84–251 0.920
Kinetic constants shown in the first three columns are average of duplicate experiments (with standard deviation) and 95% confidence intervals respectively.
*pH 3, CPO=1.8 nM, 25uC.
doi:10.1371/journal.pone.0010601.t001
Figure 2. Kinetics of CPO catalyzed peroxidation of ABTS
obtained by varying the ABTS concentration, at constant
peroxide. Initial conditions- pH 3.5, 100 mM phosphate buffer, 30uC,
[CPO]=20 nM.
doi:10.1371/journal.pone.0010601.g002
Figure 3. Kinetics of CPO catalyzed peroxidation of TMPD
obtained by varying the peroxide concentration, at constant
peroxidative substrate (TMPD). Initial conditions- pH 3.5, 100 mM
phosphate buffer, 30uC, [CPO]=20 nM.
doi:10.1371/journal.pone.0010601.g003
Heme-Enzyme Kinetics
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positive effect on the yield of product at higher substrate
concentrations.
CYP1A2 reactions with 7-EFC
In these reactions, quantification of both the expected product
(the specifically de-ethylated substrate) and the substrate was
carried out after incubation for specific times. The results are
shown in Figure 11. It could be seen that the product inhibition
occurred at much lower substrate concentrations. Also, the
amount of specific product formed did not account for the
amount of substrate depleted. Extra peaks were seen in the
chromatograms of these samples (results not shown) indicating the
formation of new products. These unidentified new products could
account for the disappearance of excess substrate (the substrate
missing and not accounted for by the formation of the expected
product of 7-hydroxyfluorocoumarin).
Discussion
Some workers in the past have probed thiolate-peroxidases as a
mechanistic model for CYP reactions, citing analogies and
differences in their modes of action [16–20]. Their arguments
relate to the details of the nature of the catalytic enzymatic species
and the precise mechanistic chemistry involved in the reaction of
the catalytic species with the substrate. Such discussions do not
dictate the context of the present work. The aspect of mechanistic
process probed here is if the ‘spatio-temporal’ idea of obstruction
of the active site by higher concentration of substrates (or an
allosteric modulation by excess substrate at an alternative enzyme
binding site), as advocated erstwhile, and as is depicted in Figure 1,
provides an adequate explanation to the ‘substrate inhibition’
kinetics.
The kinetic profiles obtained in this work indicate that the single
electron abstractions (which have been proven to not necessarily
be finally catalyzed at a unique catalytic site by CPO [10]) show a
lowered yield of product upon increasing any one of its substrates.
The data from this work indicates that lowering of product yields
at high substrate concentrations may not be owing to a process
involving interaction of the substrate and the enzyme alone, for
both CPO and CYP. Evidence presented in the reactions with
CYPs show that these observations could very well be owing to
other factors, as is shown in Figure 12. The mechanistic route
could involve:
(1) A transient intermediate (either an activated enzyme or
substrate species) could react with excess substrate to give an
alternate product, thereby lowering the product by a
competitive process. To validate this argument- (a) Schlichting
et al. have already demonstrated the existence of one and two
electron activated CYP species [21]. Also, Guengerich et al.
had earlier advocated a one-electron process mechanistic
scheme for explaining the observations in some CYP reactions
[17]. (b) Superoxide has been proposed as an essential
mechanistic component (by one of us [22]) and demonstrated
to exist in reaction milieu by many workers as a deleterious
side-product [9]. It could react very feasibly with the substrate
(which has been demonstrated earlier by one of us [22]) and
reaction product on its own merit. Such a reaction would be
anticipated to be a function of the substrate concentration,
Figure 4. Kinetics of CPO catalyzed peroxidation of Pyrogallol
(and ABTS in the inset) obtained by varying ABTS concentra-
tion to supramillimolar levels, at constant peroxide. Initial
conditions- pH 3, 100 mM phosphate buffer, 25uC, [CPO]=2 nM,
peroxide =2 mM.
doi:10.1371/journal.pone.0010601.g004
Figure 5. Steady state kinetics of reconstituted CYP2E1
enzymatic system mediated conversion of pNP with NADPH
added directly, as a function of incorporated Cytb5. Experimen-
tal details are given in methods section.
doi:10.1371/journal.pone.0010601.g005
Figure 6. State kinetics of reconstituted CYP2E1 enzymatic
system mediated conversion of pNP with NADPH regeneration
system, as a function of incorporated Cytb5. Experimental details
are given in methods section.
doi:10.1371/journal.pone.0010601.g006
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higher substrate concentration.
(1) OR/AND
(2) The product formed could get further converted by the
enzyme or yet, react with another reaction intermediate/
component present in the milieu, thereby lowering the value
of estimated product in the reaction setup. This inference has
been amply supported by data from this study.
In several CPO catalyzed peroxidations, the colored peroxida-
tion product formed was depleted in due course of the reaction on
its own or/and by the addition of excess of the peroxidative
substrate or peroxide itself (results not shown). This makes perfect
chemical sense because these reaction components are non-
specific redox sensitive molecules. CPO catalyzed chlorination
reaction milieu has already been shown to possess such chemistry
where peroxide serves both as activator and scavenger of reactive
intermediate(s) [23]. Earlier, Cassella et al had shown that the
oxidation of phenolics by CPO also exhibited a lowered product
formation at higher peroxidative substrate concentration [24]. We
found similar observation for various peroxidative substrates above
10 mM concentrations in our investigations (where solubility
permitted, results not shown).
All these observations in steady-state kinetics of fungal CPO and
microsomal CYPs indicate an analogy in the chemical reaction
Figure 7. State kinetics of reconstituted CYP2E1 enzymatic
system mediated conversion of pNP, checked for reproduc-
ibility and precision. Experimental details are given in methods
section.
doi:10.1371/journal.pone.0010601.g007
Figure 8. CYP2E1 kinetics, probed in detail using experimental
data and theoretical simulation. Experimental details are given in
methods section.
doi:10.1371/journal.pone.0010601.g008
Table 2. Analyses of CYP catalyzed peroxidations by Belanger fits.
Reaction Parameters KM (mM) Vmax (s
21) or (min-1)@ KIS (mM) R
2
CYP2E1 + pNP NADPH, control 48638 0–155 0.03460.01 0.005–0.06 9.48647.9 0–142 0.912
NADPH, x Cytb5 73617 25–120 0.5960.09 0.337–0.84 0.1360.03 0.05–0.2 0.993
NADPH, 10x Cytb5 2768 5–48 0.2660.03 0.171–0.34 0.60960.2 0.08–1.1 0.963
Regen.Sys., control 72623 9–135 0.1360.02 0.067–0.19 0.38460.1 0.04–0.7 0.983
Regen.Sys., x Cytb5 35621 0–93 0.8560.3 0.03–1.67 0.1360.07 0–0.34 0.926
Regen.Sys., 10x Cytb5 1166 0–27 0.2460.04 0.12–0.36 0.5660.28 0–1.33 0.818
25 nM 2E1, Expt 1 18.562.1 14–23 0.760.03 0.63–0.76 0.29560.03 0.23–0.4 0.982
25 nM 2E1, Expt 2 25.866.5 9.9–38 1.0760.15 0.744–1.39 0.12960.03 0.06–0.2 0.938
15 nM 2E1 33.266.2 20–47 1.0760.11 0.842–1.3 0.14860.03 0.09–0.2 0.973
25 nM, 16 points 1961.93 15–23 0.7760.03 0.71–0.82 0.39960.04 0.32–0.5 0.963
Simulated 20.662.6 15–26 0.53660.03 0.48–0.59 0.36360.04 0.3–0.44 0.970
CYP2C9 + Diclof X CYP2C9 260.8 0.2–3.8 0.12960.01 0.097–0.16 0.25560.11 0.01–0.5 0.673
2X CYP2C9 2.660.9 0.6–4.6 0.14860.02 0.12–0.18 0.1560.05 0.04–0.3 0.780
CYP1A2+ 7EFC
@ 5 minutes ,0 ,0 19.9862.81 13.9–26 23.269.32 3.1–43.4 0.822
10 minutes 1156219 0–588 39.8967.17 24.4–55.4 18.968.9 0.0–38.1 0.782
15 minutes 4776376 0–1290 64.88614.4 33.8–95.9 13.466.5 0.0–27.5 0.787
Averaged (0–15 min.) 298862544 0–9529 9.2965.19 0–22.6 4.963.9 0.0–14.9 0.915
Kinetic constants shown in the first three columns are average of duplicate experiments (with standard deviation) and 95% confidence intervals respectively.
doi:10.1371/journal.pone.0010601.t002
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microsomal CYPs catalyze via a bi-substrate route. The first
process in both enzymes is assumed to involve the oxygen donor
species binding at the heme and the second involves the final
electron donor/acceptor substrate interaction. We know that the
original activator in the CPO reaction is the redox sensitive
peroxide and if we could consider superoxide as an activator for
CYPs (as mooted earlier by one of us [22]), then the analogy would
be explained even better.
Incorporation of Cytb5 in CYP reaction milieu (as a one-
electron redox sensitive hydrophobic macromolecule) showed
clear indications that single electron processes have direct
relevance to the product formation and distribution in the milieu.
Also, earlier interpretations were that Cytb5 serves as a redox relay
between CYPs and reductase, mediating the process via a protein-
protein complexation [25,26]. If that were to be the case, increase
in Cytb5 should only increase the product yield. This is not
observed and therefore, the erstwhile hypothesis that ‘‘Cytb5 is a
protein-protein redox relay between CYP and CPR’’ is question-
able. On the other hand, if we assume Cytb5 to be a non-selective
one-electron transient scavenger cum cycler (that affects the
equilibriums involving single and two electron processes at the
lipid interface) in a non-specific redox reaction setup involving
superoxide, we could efficiently account for lowering or enhance-
ment of rates in various compositions. This is especially evident as
excess Cytb5 serves well in both CYP2E1 and CYP2C9 reactions
at higher substrate concentrations, under diverse conditions.
The concentration range of substrate at which the maximal
rates were observed (following which increase in substrate
concentrations showed a lowering in product yield) for the three
CYPs ranged around 5, 25 and 125 mM for CYP1A2: 7-EFC,
CYP2C9: diclofenac and CYP2E1: pNP respectively. This
observation is in accordance with the chemical reactivity of the
substrates. That is - the electron withdrawing nitro group and an
adjacent sterically hindering hydroxyl makes pNP molecules’
reaction centre to be less efficient. In comparison, the non-
hindered ethoxy group’s oxygen moiety’s lone pair (which is
conjugated to the p electron cloud in the coumarin derivative and
also connected to an electron donating ethyl group) would be the
most reactive and easily accessible center among the three
substrates tested. In case of the peroxidation reaction with CPO,
the active-site-excluded ABTS [10] (which has better electron
density and donating ability) shows inhibition at lower substrate
concentrations than the smaller TMPD (for a given peroxide
concentration). This is yet another consideration which indicates
that the ‘‘substrate inhibition’’ is not connected to a blocking of the
active site.
Surely, one cannot argue that there are no multiple binding sites
for the various substrates on CYP and CPO. However, it is very
difficult to imagine that enzymes like CPO and CYP family have
multiple binding sites for their diverse array of both their final
substrates and initial activator (peroxide). As per the data reported
in this study, the non-specific reaction network put forward in
Figure 9. CYP2C9 baculosomes show lowering of specific
hydroxylation of diclofenac upon increasing substrate con-
centration. A final concentration of 1 mM NADPH was used. 5 and
10 ml of the commercial enzyme preparation was added to 1 ml of the
reaction mixture.
doi:10.1371/journal.pone.0010601.g009
Figure 10. Reconstituted CYP2C9 system shows depletion of
specific hydroxylated product over time. Initial concentrations are
,0.08 uM of CYP2C9 = CPR, 0.04 to 0.8 uM Cytb5, 1 mM NADPH. Other
details are mentioned in the experimental section.
doi:10.1371/journal.pone.0010601.g010
Figure 11. Reconstituted CYP1A2 system shows that the
specific hydroxylated product formed does not account for
the total substrate converted in the reaction. Initial concentra-
tions were [CPR]=200 nM, [CYP1A2]=100 nM, [DLPC]=20 mM,
[NADPH]=500 mM & varying [7EFC] stocks in DMSO were added at a
final concentration of 1% of the cosolvent.
doi:10.1371/journal.pone.0010601.g011
Heme-Enzyme Kinetics
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express a note of caution towards the data and interpretations
published in a recent article [27]. The authors therein have
reported kinetic and equilibrium constants for effector site
modulations (alternate term for substrate inhibitions) in the
activity of CYP2E1-pNP reaction mixtures. We have exhaustively
worked on the same system and ascertained that it is impossible to
derive any reproducible and meaningful kinetic constants for
steady state kinetics using experimental data by non-linear
regression analyses with available kinetic treatments or software.
As can be evident from a visual examination of Figure 2 from their
communication, the theoretical fits do not do justice to the
experimental data. Specifically, the rates at the point of inflexion
(where maximum activities are obtained) and higher substrate
concentrations (the region that the hypothesis supposedly accounts
for!) clearly go out of the fit. These outliers are real and not just
instances of experimental error, as hitherto considered. With much
lesser standard deviations of individual points, better R
2 values
than the data reported therein and with more number of points
spread through the curve, the value of KIS obtained with Dynafit
plots in our work ranged from ,100 mMt o,10 mM in simple
control reactions that did not include any inhibitor. When
molecules (inhibitors) like 4-methylpyrazole and isoquinoline were
added (in our study, results not shown), the complexities for
determining KI and KIS only increased manifold. The fits then
pointed to an uncompetitive or noncompetitive model, at times a
mixed model and in some instances, the fitted curve could hardly
be called a fit! Therefore, it is our view that attempts to draw any
interpretations from such poor fits and inappropriate hypothesis
would only lead one to erroneous conclusions. Merely, getting an
R
2 value above 0.9 is no indication that the hitherto proposed
model has fidelity to the equation or mechanism. An exhaustive
study of the two tables presented herewith (along with the
respective figures) would convince any careful reader of the above
statement.
The simulation of kinetics (and fitting thereof) could be achieved
better using a biphasic treatment, with the incorporation of new
meaningful constants. The fitting (for rate Y versus substrate
concentration X) could be done with the following simple
algorithm, using two intermediate variables (Y1 & Y2) and six
true variables-
Y1 ~ V1   X = K1 z X ðÞ
Ymax ~ V1   Xmax = K1 z Xmax ðÞ
Y2 ~ Ymax V2   X - Xmax ðÞ ðÞ = K2 z X - Xmax ðÞ ðÞ ½ 
Y ~ IF X v Xmax ðÞ , Y1, Y2 ½ 
The last expression is a logic statement in the algorithm used to
fit data serving to demarcate the two hyperbolic phases with
(Xmax,Y max) as the node. Of the six true variables, V1 &K 1 are
the theoretical constants for ascending part & V2 &K 2 are the
theoretical constants for the descending part. The practically
observable and ascertainable Ymax (the maximum observable rate)
and Xmax (the concentration of substrate at which maximum rate
is observed) values are the new concepts introduced here. The
latter values could convey more meaningful information of a given
reaction system in which ‘substrate inhibition’ is expected or
observed. The re-analyses of experimental data for CPO’s reaction
profile with pyrogallol (Figure 4) with the new fitting method gave
an R
2 value =0.994. The result is shown in Figure 13. When data
from Figure 8 (for CYP2E1’s experimental reaction profile with
pNP) was refitted using the new method, an R
2 value =0.983 was
derived with the points falling much better onto the fitted curve
(results are shown in Figure 14). These show that the novel
biphasic treatment gives a far more satisfactory fit, as is
determined with a simple visual verification. Other details of
fitting and data obtained thereof shall be discussed in a
forthcoming communication.
To conclude, the hemoprotein reaction milieu with two
substrates (or more) involves several competing reactions. The
exact nature of the product(s) formed and their distribution thereof
Figure 12. The newly proposed mechanistic possibilities in reactions catalyzed by hemoproteins are shown. At the left are two-
electron (top) and one-electron (bottom) oxidized enzyme intermediates, giving rise to two-electron (top) and one-electron (lower) oxidized product
or intermediates in the center. The final products that could be formed are shown to the right.
doi:10.1371/journal.pone.0010601.g012
Heme-Enzyme Kinetics
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reaction conditions and reactant concentrations. Algorithms need
to be developed to predict the probabilistic course of such a
reaction, given a hemoprotein reaction mixture. These efforts
would have far-reaching impact in our understanding of cellular
and physiological processes involving these maverick enzymes.
Materials and Methods
The chemicals and reagents used were of analytical grade,
purchased from Sigma, Lancaster (USA) and SD Fine Chemicals
(India). For procedural details on CPO, please refer to our recent
publication [10]. The source of CYPs was either a commercial
baculosome preparation from Invitrogen (PanVera) or reconsti-
tuted systems made in lab. For the production, purification and
processing of CYP and associated proteins, please refer to an
earlier publication [28].
General conditions
CPO reactions were carried out in open with ,20 nM CPO at
,3062uC, 100 mM phosphate buffer (Figures 1 through 6). The
selection of pH value employed simple logic to optimize between
autocatalytic rates and enzyme-catalyzed rates. Pyrogallol reac-
tions were incubated at pH 5, ABTS [2,29-azino-bis(3-ethyl-
benzthiazoline-6-sulphonic acid)] reactions were incubated at
pH 3.5 and tetramethyl phenylene diamine (TMPD) reactions
were incubated at pH 2.75. All CYP reaction incubations were
done in aerated open vials at 3761uC in 100 mM phosphate
buffer, pH 7.4. Unless otherwise mentioned, reconstituted systems
had 10 mg/ml of 0.2 mm vesicles of dilauryl phosphatidylcholine
(DLPC, Avanti Lipids). Besides the general procedures mentioned
below, specific components’ concentrations and other details are
mentioned in the legends to the corresponding figures.
Reactions with CYP2E1
The reactions contained 20 mM DLPC, 15 nM CYP2E1,
60 nM CPR, 0/50/500 nM cytochrome b5 (Cytb5) and the
appropriate concentrations of para-nitrophenol (pNP). 200 mlo f
the regeneration system reaction mixture had - 0.3 mlo f2M
MgCl2, 2.4 mlo f5 mg/ml of superoxide dismutase, 0.6 mlo f
1000 Units/ml catalase, 0.6 ml of 1 Unit/ml glucose-6-phosphate
dehydrogenase & 60 ml of glucose-6-phosphate. The reactions
were initiated with the addition of 500 mM NADP
+ in the
regeneration system reaction and 500 mM NADPH in another set.
The HPLC protocol for quantification of product of para-
nitrocatechol (pNC) was similar to a procedure reported recently
[27]. Aliquots of the reaction mixture were taken at 6, 12 and 18
minutes and the rate of production of pNC was calculated by the
slope of linear plot obtained.
Reactions with CYP2C9
In another reaction involving reconstituted enzymes, 80 nM
CYP + 80 nM CPR mixture was used. Cytb5 was in the range of
40 to 800 nM (Figure 13). Termination of reaction for product
quantification was achieved by adding 200 ml of a cold solvent
mixture (94% acetonitrile + 6% acetic acid, containing tert-butyl
phenol as the internal standard) to 500 ml of sample. Conversion of
diclofenac (Diclof) was determined using Alltima C18 5 m HPLC
column (150 mm63.2 mm) from Alltech. The solvent system of
70% (of 30% acetonitrile in water with 1 mM perchloric acid) and
30% methanol was pumped at 0.8 ml/min. Chromatography was
monitored with a UV detector at 267 and 275 nm. Elution times
and areas of standard samples of diclofenac and its 39,4 9 &5 9
hydroxylated derivatives were used for detecting and quantifying
the products. Under the conditions employed, 49hydroxydiclofe-
nac and diclofenac eluted at ,6 and 7.5 minutes respectively.
Reactions with CYP1A2
At designated incubation intervals (5, 10 & 15 minutes), 75 mlo f
the reaction sample was taken and quenched with 25 mlo f
acetonitrile containing the internal standard and centrifuged. An
appropriate amount (usually 40 ml of the supernatant) was injected
for HPLC. The product formed was estimated from the slope of
line formed by fitting a standard linear plot. For the quantification
of 7-hydroxy trifluoromethylcoumarin (7-HFC), the de-ethylated
product of CYP1A2 oxidation of 7-ethoxy trifluoromethylcou-
marin (7-EFC), a Symmetry C18 3.5 mm column from Waters was
employed. A binary solvent system- solvent A=75% of 0.1%
trifluoroacetic acid in water & solvent B = acetonitrile were taken
with a gradient method. The details are 0 min =1 ml/min, 75%
A + 25% B; 4 min=1.5 ml/min, 75% A + 25% B; 9 min=
1.5 ml/min, 0% A + 100% B; 11 min=1.5 ml/min, 75% A +
25% B & 12 min=1 ml/min, 75% A + 25%B. A fluorescence
detector with excitation and emission wavelengths set at 385 nm
and 500 nm respectively was used to quantify the reactants and
products. The UV absorption profiles of products were also
followed in certain reactions. The analytes 7-hydroxycoumarin (an
Figure 13. The new biphasic fit is plotted for CPO mediated
peroxidation profile for conversion of pyrogallol from Figure 4.
doi:10.1371/journal.pone.0010601.g013
Figure 14. The new biphasic fit is plotted for CYP2E1 mediated
hydroxylation profile for conversion of pNP from Figure 8.
doi:10.1371/journal.pone.0010601.g014
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,2.6, 8.2 and 9.6 minutes respectively.
Fitting and analyses of kinetics data
Non-linear (and linear) regression analyses of enzyme kinetics
were carried out using Dynafit and GraphPad Prism software for
uncompetitive substrate inhibition (Belanger fit):
V ~ (Vmax   S)= Km z S1 z S=KIS ðÞ ½ 
The constraints were only experimental values were taken (0,0
excluded) and Vmax,K M and KIS.0. Both Dynafit and Prism
outputs gave similar values of constants for all reactions studied
herein and therefore, only the latter is reported. For theoretical
simulation (as shown by the triangles in Figure 9), the data were
derived using a fusion of two equations, in a biphasic treatment.
The ascending points [until the blackened point- (75, 0.4) in
Figure 9] were derived using the ascending hyperbola equation:
Y ~ 0:5X = 20 z X ðÞ
The descending points [from the blackened triangle point-
(75, 0.4)] were derived using the descending hyperbola equation:
Y ~ 0:4 - 0:25 X - 75 ðÞ = 200 z X - 75 ðÞ ðÞ ½ 
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